K E Thummel

First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayers.

P. Watkins, S. Wrighton, D. Shen, 1999, The Journal of pharmacology and experimental therapeutics.

Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.

E. Kharasch, C. Jubert, K. Thummel, 1999, Drug metabolism and disposition: the biological fate of chemicals.

THE HUMAN CYP3A SUBFAMILY: PRACTICAL CONSIDERATIONS*

P. Watkins, S. Wrighton, E. Schuetz, 2000, Drug metabolism reviews.

Influence of stiripentol on cytochrome P450‐mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants

R H Levy, W. Trager, K. Thummel, 1997, Clinical pharmacology and therapeutics.

Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.

D. Shen, C. Marsh, J. Perkins, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization.

J T Slattery, J. Chien, K. Thummel, 1997, Drug metabolism and disposition: the biological fate of chemicals.